Olivier Chinot
Olivier Chinot
Professeur d'Oncologie, Aix-Marseille Université
Verified email at ap-hm.fr
Title
Cited by
Cited by
Year
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ...
New England Journal of Medicine 370 (8), 709-722, 2014
19652014
Radiotherapy for glioblastoma in the elderly
F Keime-Guibert, O Chinot, L Taillandier, S Cartalat-Carel, M Frenay, ...
New england journal of medicine 356 (15), 1527-1535, 2007
7782007
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
6092017
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
M Weller, M van den Bent, K Hopkins, JC Tonn, R Stupp, A Falini, ...
The lancet oncology 15 (9), e395-e403, 2014
5872014
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
5452017
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
BG Baumert, ME Hegi, MJ van den Bent, A von Deimling, T Gorlia, ...
The lancet oncology 17 (11), 1521-1532, 2016
3192016
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor …
MJ Van den Bent, MJB Taphoorn, AA Brandes, J Menten, R Stupp, ...
Journal of clinical oncology 21 (13), 2525-2528, 2003
2982003
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ...
Acta neuropathologica 120 (6), 719-729, 2010
2772010
Recent trends in epidemiology of brain metastases: an overview
E Tabouret, O Chinot, P Metellus, A Tallet, P Viens, A Goncalves
Anticancer research 32 (11), 4655-4662, 2012
2582012
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
2522017
Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of …
T Sandmann, R Bourgon, J Garcia, C Li, T Cloughesy, OL Chinot, W Wick, ...
Journal of clinical oncology 33 (25), 2735, 2015
2492015
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research …
K Hoang-Xuan, L Taillandier, O Chinot, P Soubeyran, U Bogdhan, ...
Journal of Clinical Oncology 21 (14), 2726-2731, 2003
2362003
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide
OL Chinot, M Barrie, S Fuentes, N Eudes, S Lancelot, P Metellus, ...
Journal of Clinical Oncology 25 (12), 1470-1475, 2007
2282007
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas
A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ...
Clinical cancer research 18 (19), 5203-5211, 2012
2142012
Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and …
V Quillien, A Lavenu, L Karayan‐Tapon, C Carpentier, M Labussière, ...
Cancer 118 (17), 4201-4211, 2012
2022012
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy
OL Chinot, S Honore, H Dufour, M Barrie, D Figarella-Branger, ...
Journal of clinical oncology 19 (9), 2449-2455, 2001
1932001
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
OL Chinot, TLM Rouge, N Moore, A Zeaiter, A Das, H Phillips, ...
Advances in therapy 28 (4), 334-340, 2011
1902011
Phase II-Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations-Author reply
OL Chinot
CANCER 101 (12), 2898-2899, 2004
1702004
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
OL Chinot, M Barrie, E Frauger, H Dufour, D Figarella‐Branger, J Palmari, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2004
1702004
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study
A Carpentier, P Metellus, R Ursu, S Zohar, F Lafitte, M Barrie, Y Meng, ...
Neuro-oncology 12 (4), 401-408, 2010
1682010
The system can't perform the operation now. Try again later.
Articles 1–20